The effect of two golimumab doses on radiographic progression in ankylosing spondylitis: results through 4 years of the GO-RAISE trial

OBJECTIVE: To evaluate radiographic progression in patients with ankylosing spondylitis (AS) receiving two different doses of the tumour necrosis factor antagonist golimumab. METHODS: 356 patients with AS were randomly assigned to placebo, or golimumab 50 mg or 100 mg every 4 weeks (wks). At wk16, p...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Braun, Jürgen, Baraliakos, Xenofon, Hermann, Kay-Geert A, Deodhar, Atul, van der Heijde, Désirée, Inman, Robert, Beutler, Anna, Zhou, Yiying, Xu, Stephen, Hsu, Benjamin
Formato: Artigo
Idioma:Inglês
Publicado em: BMJ Publishing Group 2014
Assuntos:
Clinical and Epidemiological Research
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4033110/
https://ncbi.nlm.nih.gov/pubmed/23644549
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/annrheumdis-2012-203075
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados